Mon-Fri 9am-6pm PST
+1 (800) 686-5898
support@longevitybased.com
Mon-Fri: 9am-6pm PST
Berberine is often hailed as “nature’s metformin,” with claims ranging from weight loss and blood sugar control to cholesterol reduction and even cancer prevention. But how much of this is marketing—and how much is backed by science?
In this article, we’ll cut through the hype and explore what the research actually says about berberine. We’ll look at its effects on cholesterol, blood sugar, and metabolic health, as well as where it might fit into a smart, evidence-based treatment plan.
Berberine is a bioactive compound found in various plants, long used in traditional Chinese medicine for treating infections like diarrhea. More recently, it's attracted scientific interest for its potential in managing metabolic syndrome, type 2 diabetes, and cholesterol.
In lab studies, berberine has shown anti-cancer properties—killing cancer cells in petri dishes from breast, colon, lung, prostate, and liver tumors. It has also been shown to enhance certain cancer therapies in vitro. However, this research is still in its early stages, and promising results in lab settings often fail to translate into effective treatments in humans. At this stage, there’s not enough clinical evidence to consider berberine a cancer-fighting supplement.
Berberine helps reduce LDL (bad) cholesterol through multiple mechanisms:
Decreasing dietary cholesterol absorption in the gut
Increasing LDL receptors in the liver (which clear LDL from the bloodstream)
Reducing PCSK9, a protein that breaks down those LDL receptors
A 2018 meta-analysis of 16 clinical trials found that berberine slightly reduced total and LDL cholesterol while boosting HDL (good) cholesterol. A 2024 update found similar results, but researchers noted that the quality of studies varied, and effects were modest.
Berberine activates an enzyme called AMPK, often referred to as a “metabolic master switch.” This enzyme helps regulate blood sugar and energy balance—similar to the prescription drug metformin.
A 2021 meta-analysis of 46 trials found that berberine lowered hemoglobin A1C (a key marker of long-term blood sugar) by 0.38%, which is borderline clinically significant. It also reduced fasting glucose and post-meal blood sugar levels—comparable in some cases to metformin.
One small trial even found that berberine slightly outperformed metformin, but this study only included 36 participants over three months. In contrast, metformin has decades of high-quality, long-term data behind it. That’s why clinical guidelines continue to recommend metformin, not berberine, for type 2 diabetes.
Some influencers claim berberine is “nature’s Ozempic,” but the comparison is exaggerated. A 2020 meta-analysis found that berberine led to an average weight loss of about 2 kg. A more recent review found results closer to 1 kg.
Compare that to GLP-1 medications like semaglutide (Ozempic), which in clinical trials produced average weight loss of 15 kg over 68 weeks. In short, berberine may offer a small weight benefit—but it’s nowhere near as potent as the real thing.
Because berberine activates AMPK—just like metformin—some have speculated it might help slow aging. However, studies on metformin have not shown a consistent benefit in healthy individuals.
In fact, in non-diabetics, metformin failed to prevent cardiovascular disease or extend lifespan in long-term studies. Some trials even showed it reduced the positive effects of exercise and lowered testosterone levels.
We have very limited data on whether berberine has similar side effects, but animal studies suggest it may reduce muscle protein synthesis and impair muscle growth. That’s one reason I do not include berberine in general health supplements like multivitamins—especially for otherwise healthy people.
Lifestyle changes like diet, exercise, and sleep are always the foundation of metabolic health. But when medications are needed, we rely on treatments with proven safety and effectiveness.
Here’s how to approach it:
For high blood sugar: Metformin remains the first-line treatment. GLP-1 medications are now the top choice for aggressive weight loss or more advanced diabetes.
For high cholesterol: I usually start with low-dose statins like rosuvastatin or pravastatin. If a patient can’t tolerate statins, I’ll add ezetimibe or consider PCSK9 inhibitors or bempedoic acid—but these can be expensive.
This is where berberine sometimes fits in. If a patient:
Can’t tolerate statins,
Can’t afford or access PCSK9 inhibitors, and
Still needs further cholesterol reduction,
…then berberine may be considered as a low-cost, low-risk option. But it’s a last resort, not a replacement for established medications. We also lack the outcome data to prove it reduces heart attacks or strokes.
Berberine is a promising compound, especially for those with metabolic issues who can’t tolerate conventional medications. But while it may modestly improve cholesterol, blood sugar, and weight, its effects are small compared to prescription therapies—and the long-term data just isn’t there yet.
If you're otherwise healthy, the risks may outweigh the benefits. But for certain cases, especially involving statin intolerance, berberine might be a useful tool as part of a broader treatment plan.
Always speak with your healthcare provider before starting any supplement—especially one that could impact blood sugar or cholesterol levels.
Research sources:
https://pubmed.ncbi.nlm.nih.gov/28444290/
https://onlinelibrary.wiley.com/doi/10.1002/jbt.70073
https://www.uptodate.com/contents/lipid-management-with-diet-or-dietary-supplements
https://www.ncbi.nlm.nih.gov/books/NBK519561/
https://pubmed.ncbi.nlm.nih.gov/30466986/
https://pubmed.ncbi.nlm.nih.gov/39640489/
https://pmc.ncbi.nlm.nih.gov/articles/PMC8696197/
https://pmc.ncbi.nlm.nih.gov/articles/PMC2410097/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3135022/
https://pubmed.ncbi.nlm.nih.gov/32690176/
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
https://pmc.ncbi.nlm.nih.gov/articles/PMC5013015/
https://pmc.ncbi.nlm.nih.gov/articles/PMC6351883/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9321693/
https://pmc.ncbi.nlm.nih.gov/articles/PMC8740051/
https://pmc.ncbi.nlm.nih.gov/articles/PMC2911075/
https://pubmed.ncbi.nlm.nih.gov/39930016/
https://www.cochrane.org/CD004816/VASC_statins-primary-prevention-cardiovascular-disease